Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs.
D000227:Adenine Nucleotides / Q000378:metabolism*; D000818:Animals; D002417:Cattle; D003331:Coronary Vessels / Q000201:enzymology; D000242:Cyclic AMP / Q000378:metabolism; D003864:Depression, Chemical; D004176:Dipyridamole / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009206:Myocardium / Q000201:enzymology*; D010208:Papaverine / Q000008:administration & dosage / Q000494:pharmacology*; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors*; D011299:Prenylamine / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000227:Adenine Nucleotides; D007546:Isoquinolines; D014665:Vasodilator Agents; D004176:Dipyridamole; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D011299:Prenylamine